Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies
Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies
Genscript生物科技簽署反PD-1單域抗體分許可合同
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊